It's also accredited for Older people who will be overweight with one or more pounds-relevant situations, which include significant blood pressure or Sort two diabetic issues (superior blood sugar). In March of 2024, the FDA approved a further indicator for Wegovy—to lessen the risk of cardiovascular death, coronary heart attack, https://glp-1weightlossmed.com/product/wegovy/